ArticleOncology letters2020

The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells.

Alejandro Schcolnik-Cabrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.